This division has been a part of the NIH initiative to identify disease modifying therapies for PD (the NET-PD trials) since its inception more than 10 years ago, and is a participating site in the new NIH clinical trials initiative NeuroNEXT (Network for Excellence in Neuroscience Clinical Trials).